Navigation Links
Kendle Executive to Share Insights at World Pharma Trials Asia 2010

CINCINNATI, March 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Dr. Ross Horsburgh, Vice President, Asia/Pacific will address the World Pharma Trials Asia 2010 conference being held March 17-18, 2010 at the Raffles City Convention Centre in Singapore. Dr. Horsburgh's presentation, "Accelerating Oncology Clinical Development in Asia," is scheduled for March 18 at 2 p.m. local time.  World Pharma Trials Asia brings together pharmaceutical companies, biotechnology companies and CROs to explore outsourcing opportunities in Asia.

Dr. Horsburgh's presentation will explore key opportunities and challenges in oncology development in the region, discuss the benefits of including Asian countries in global development plans for oncology, define key success factors for conducting these trials in Asia and discuss best practices in selecting the optimal sites for exploratory oncology trials.  

Following the conference, Dr. Horsburgh's presentation will be posted to the Kendle Web site at

Dr. Horsburgh is a trained medical physician with more than 20 years of experience in the CRO and pharmaceutical industries.  He is responsible for the strategic oversight of all of Kendle's operations throughout the Asia/Pacific region, which includes offices in Beijing, Hong Kong and Shanghai, China; Ahmedabad and New Delhi, India; Kuala Lumpur, Malaysia; Bangkok, Thailand; Manila, Philippines; Sydney and Melbourne, Australia and Singapore.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at

SOURCE Kendle International Inc.

Back to top



SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
2. Kendle Launches New Global Biostatistics Infrastructure
3. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
4. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
5. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
6. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
7. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
8. ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors
9. Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing
10. Top Bristol-Myers Squibb Executive Joins Patton Boggs
11. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
Post Your Comments:
(Date:11/24/2015)... NEWS, Va. , Nov. 24, 2015  DILON ... they have signed an agreement for DILON to distribute ... geographies across the globe. The signing of this distribution agreement ... Discovery NM750b Molecular Breast Imaging system and is considered ... to provide better healthcare solutions for clinicians and their ...
(Date:11/24/2015)... , Nov. 24, 2015 Avery Biomedical ... is pleased to announce the appointment of Anders ... Dr. Jonzon ... cardiology at Children,s Hospital, Uppsala University, Uppsala and Children,s ... 1984-1986, he was a fellow at the Cardiovascular Institute ...
(Date:11/24/2015)... LAUSANNE and BERN, Switzerland ... SA, the ARTORG Center for Biomedical Engineering Research of ... and the Division of Endocrinology, Diabetes and Clinical Nutrition ... announce the start of an exclusive collaboration to develop ... control algorithm for the personalised delivery of insulin for ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 24, 2015 , ... It takes only three to five seconds ... critical that the first impression be positive and reflects business values. If a client ... anything or want to return. They will also share their thoughts about a business ...
(Date:11/24/2015)... ... November 24, 2015 , ... Brillouin ... System. Brillouin is the developer of renewable energy technologies capable of producing commercially ... (“LENR”), announced today that its WET™ and HHT™ Boiler System reactor core modules ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... is pleased to welcome Winter-Dent & Company as its newest Partner Firm. Based ... to become a client's most trusted advisor regardless of whether that client is ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the United States to support their local poison centers through donations on Tuesday, ... #GivingTuesday: calls it “a day that inspires people to collaborate in improving ...
(Date:11/24/2015)... ... November 24, 2015 , ... Serenity Point Rehabilitation, a ... of recent video interviews with some of the staff members at their recovery center. ... treatment facility, as well as some of the things that make their recovery program ...
Breaking Medicine News(10 mins):